Colgate Announces 4th Quarter and Full Year 2023 Results

Rhea-AI Summary

Colgate-Palmolive Company (NYSE:CL) reported a 7.0% increase in net sales and organic sales for the fourth quarter and an 8.5% increase for the full year 2023. The company's Chairman, President, and CEO expressed satisfaction with the strong top and bottom line results, including growth in net and organic sales, improved organic volume performance, and increased earnings per share. The company also saw growth in gross profit margin, operating profit margin, net income, and free cash flow. Full-year total net sales were $19,457 million, with a 30% increase in GAAP EPS to $2.77. Base Business EPS increased 9% to $3.23. Colgate-Palmolive also provided guidance for 2024, expecting net sales growth to be 1% to 4%, including a low-single-digit negative impact from foreign exchange, and organic sales growth within the 3% to 5% targeted range. The company anticipates gross profit margin expansion, increased advertising investment, and double-digit earnings-per-share growth on a GAAP basis, and mid to high-single-digit earnings-per-share growth on a non-GAAP basis.

Insights

Financial Analyst

The reported financial results of Colgate-Palmolive Company show a robust performance, with net and organic sales growth of 7.0% and 8.5% for the fourth quarter and full year, respectively. This consistent growth, particularly surpassing the company's targeted range for organic sales, reflects a strong consumer demand and effective business strategies. The significant 30% increase in GAAP EPS and 9% increase in Base Business EPS indicate improved profitability, which is particularly notable given the goodwill and intangible assets impairment charges the company lapped from the previous year.

From a financial perspective, the gross profit margin expansion by 400 basis points to 59.6% is a key highlight, as it suggests enhanced operational efficiency and cost management. The 47% increase in net cash provided by operations is also a strong indicator of healthy cash flow management. Investors should note the company's market leadership in toothpaste and manual toothbrushes, with significant global market shares, as this dominance in essential categories provides a stable revenue base and potential for continued market penetration. The guidance for 2024, with expected net sales growth and organic sales within the targeted range, alongside planned gross profit margin expansion and increased advertising investment, suggests a proactive approach to sustaining growth and brand strength in a competitive market.

Market Research Analyst

Colgate-Palmolive's performance can be attributed to its strategic investments in innovation, digital, data and analytics, revenue growth management and advertising. The 19% increase in advertising spending reflects a commitment to brand building, which is critical in the consumer goods sector for maintaining brand loyalty and market share. The company's ability to grow organic sales across all divisions and categories indicates a diversified and resilient product portfolio, which is essential in mitigating risks associated with market volatility.

It's also worth noting that the company's success comes amidst a backdrop of global economic challenges, suggesting that Colgate-Palmolive's products are viewed as essential consumer staples with inelastic demand. The anticipated low-single-digit negative impact from foreign exchange in the 2024 guidance highlights the company's exposure to global currency fluctuations, which is an important consideration for investors looking at international operations and its impact on financial performance.

Consumer Behavior Specialist

The reported results and forward-looking statements provide insights into consumer behavior trends. Colgate-Palmolive's growth in organic sales suggests that consumers are continuing to prioritize trusted brands for personal care and hygiene products, which may reflect an ongoing trend towards health and wellness. The company's investment in digital and analytics capabilities indicates an awareness of the importance of personalized marketing and consumer engagement in driving sales.

Looking ahead, the company's focus on advertising and brand investment is likely an attempt to further solidify consumer loyalty and attract new customers in a competitive landscape. The guidance for 2024, with its emphasis on organic sales growth within the long-term target range, suggests confidence in the company's ability to maintain consumer relevance and adapt to changing market conditions.

4Q 2023 Net sales and Organic sales both increased 7.0%

Full Year 2023 Net sales and Organic sales both increased 8.5%

NEW YORK--(BUSINESS WIRE)-- Colgate-Palmolive Company (NYSE:CL) today reported results for fourth quarter and full year 2023. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business fourth quarter and full year results, “We are pleased to have finished the year with another quarter of strong top and bottom line results including 7.0% net and organic sales growth, improved organic volume performance, gross and operating profit margin expansion and double-digit earnings per share growth.

“For the full year, we grew both net and organic sales 8.5%, with organic sales growth in every division and in all four of our categories. This was our fifth consecutive year with organic sales growth at or above our 3% to 5% targeted range.

“The strong sales growth combined with our commitment to productivity and efficiency drove strong bottom line performance as well, with gross profit, gross profit margin, operating profit, operating profit margin, net income, earnings per share and free cash flow all increasing versus 2022 for both the quarter and the year.

“We continued to invest in the capabilities required to deliver robust growth going forward, building strength in areas like innovation, digital, data and analytics, revenue growth management and advertising. We leveraged our strong margin performance to invest behind building our brands, with a 19% increase in advertising spending in 2023, and we expect higher levels of brand investment in 2024.

“The quality of our results this year and our strong growth momentum, including improved organic volume performance, add to our confidence that we are well positioned to deliver consistent, compounded earnings per share growth in 2024 and beyond.”

Full Year

• Net sales and Organic sales* both increased 8.5%
• GAAP EPS increased 30% to $2.77 as we lapped goodwill and intangible assets impairment charges in fourth quarter 2022
• Base Business EPS* increased 9% to $3.23

Full Year Total Company Results (GAAP)
($ in millions except per share amounts)	2023	2022	Change
Net Sales	$19,457	$17,967	+8.5%
EPS (diluted)	$2.77	$2.13	+30%
Full Year Total Company Results (Base Business - Non-GAAP)*
($ in millions except per share amounts)	2023	2022	Change
Organic Sales Growth			+8.5%
Base Business EPS (diluted)	$3.23	$2.97	+9%

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 7 - Geographic Sales Analysis Percentage Changes” and “Table 9 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Fourth Quarter

• Net sales and Organic sales* both increased 7.0%
• GAAP EPS increased to $0.87 as we lapped goodwill and intangible assets impairment charges in fourth quarter 2022
• Base Business EPS* increased 13% to $0.87
• GAAP Gross profit margin and Base Business Gross profit margin* both increased 400 basis points to 59.6%
• Net cash provided by operations was $3,745 for the full year, up 47% versus 2022
• Colgate’s leadership in toothpaste continued with its global market share at 41.1% year to date
• Colgate’s leadership in manual toothbrushes continued with its global market share at 31.5% year to date

Fourth Quarter Total Company Results (GAAP)
($ in millions except per share amounts)	2023	2022	Change
Net Sales	$4,950	$4,629	+7.0%
EPS (diluted)	$0.87	$0.01	NM
Fourth Quarter Total Company Results (Base Business - Non-GAAP)*
($ in millions except per share amounts)	2023	2022	Change
Organic Sales Growth			+7.0%
Base Business EPS (diluted)	$0.87	$0.77	+13%

NM - Not Meaningful

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” and “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Full Year 2024 Guidance

Based on current spot rates:

• The Company expects net sales growth to be 1% to 4% including a low-single-digit negative impact from foreign exchange.
• The Company expects organic sales growth to be within its long-term targeted range of 3% to 5%.
• On a GAAP basis, the Company expects gross profit margin expansion, increased advertising investment and double-digit earnings-per-share growth.
• On a non-GAAP (Base Business) basis, the Company expects gross profit margin expansion, increased advertising investment and mid to high-single-digit earnings-per-share growth.

Divisional Performance

The following are comments about divisional performance for fourth quarter 2023 versus the year ago period. See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.

Fourth Quarter Sales Growth By Division (% change 4Q 2023 vs. 4Q 2022)
	Net Sales	Organic Sales*	As Reported Volume	Organic Volume	Pricing	FX
North America	+3.5%	+3.5%	+0.5%	+0.5%	+3.0%	—%
Latin America	+18.0%	+16.5%	+8.0%	+8.0%	+8.5%	+1.5%
Europe	+10.0%	+3.5%	-4.0%	-4.0%	+7.5%	+6.5%
Asia Pacific	+0.5%	+1.0%	-4.5%	-4.5%	+5.5%	-0.5%
Africa/Eurasia	-4.0%	+17.0%	+7.5%	+7.5%	+9.5%	-21.0%
Hill's	+5.0%	+4.5%	-4.0%	-4.0%	+8.5%	+0.5%
Total Company	+7.0%	+7.0%	—%	—%	+7.0%	—%

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Fourth Quarter Operating Profit By Division ($ in millions)
	4Q 2023	% Change vs 4Q 2022	% to Net Sales	Change in basis points vs 4Q 2022 % to Net Sales
North America	$242	19%	24.2%	+310
Latin America	$366	26%	30.7%	+200
Europe	$140	35%	20.5%	+380
Asia Pacific	$203	12%	29.0%	+300
Africa/Eurasia	$59	-15%	22.3%	-300
Hill's	$231	-1%	20.7%	-130
Total Company, As Reported	$1,072	431%	21.7%	+1,730
Total Company, Base Business*	$1,074	14%	21.7%	+140

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures” later in this release for definitions of non-GAAP financial measures and to “Table 8 - Non-GAAP Reconciliations” included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

North America (20% of Company Sales)

• Organic sales growth was led by oral care and personal care.
• In the United States, Colgate's share of the toothpaste market is 33.7% year to date and its share of the manual toothbrush market is 41.1% year to date.
• The increase in Operating profit as a percentage of Net sales was primarily due to cost savings from the Company’s funding-the-growth initiatives, lower overhead expenses and higher pricing, partially offset by increased advertising investment.

Latin America (24% of Company Sales)

• Organic sales growth was led by Argentina, Mexico, Brazil and Colombia.
• The increase in Operating profit as a percentage of Net sales was primarily due to higher pricing, savings from the Company’s funding-the-growth initiatives and lower raw and packaging material costs, despite higher foreign exchange transaction costs, partially offset by losses on marketable securities and a gain on the sale of other assets and a value-added tax refund in fourth quarter 2022.

Europe (14% of Company Sales)

• Organic sales growth in the United Kingdom, the Nordic region and Poland was partially offset by organic sales declines in the Filorga business and Italy.
• The increase in Operating profit as a percentage of Net sales was primarily due to cost savings from the Company’s funding-the-growth initiatives and higher pricing, partially offset by significantly higher raw and packaging material costs.

Asia Pacific (14% of Company Sales)

• Organic sales growth in India and Australia was partially offset by organic sales declines in the Greater China region and Thailand.
• The increase in Operating profit as a percentage of Net sales was primarily due to cost savings from the Company's funding-the-growth initiatives and higher pricing, partially offset by higher overhead expenses.

Africa/Eurasia (5% of Company Sales)

• Organic sales growth was led by Turkiye, the Eurasia region, Nigeria and South Africa.
• The decrease in Operating profit as a percentage of Net sales was primarily due to higher raw and packaging material costs predominantly driven by significant foreign exchange transaction costs, higher overhead expenses and increased advertising investment, partially offset by higher pricing and cost savings from the Company’s funding-the-growth initiatives.

Hill's Pet Nutrition (23% of Company Sales)

• Organic sales growth was led by the United States and Europe.
• The decrease in Operating profit as a percentage of Net sales was primarily due to significantly higher raw and packaging material costs, increased advertising investment and start-up costs associated with a new manufacturing plant, partially offset by higher pricing and cost savings from the Company’s funding-the-growth initiatives.

Prepared Materials and Webcast Information

At approximately 7:00 a.m. ET today, Colgate will post its prepared materials (in PDF format) regarding fourth quarter and full year 2023 results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.

At 8:30 a.m. ET today, Colgate will host a conference call regarding fourth quarter and full year 2023 results. To access this call as a webcast, please go to Colgate’s website at www.colgatepalmolive.com.

About Colgate-Palmolive

Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children’s oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.7 billion children and families since 1991. For more information about Colgate’s global business and how we are building a future to smile about, visit www.colgatepalmolive.com. CL-E

The Company's annual meeting of stockholders is currently scheduled for Friday, May 10, 2024.

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange, the impact of the war in Ukraine, the impact of the Israel-Hamas war, cost-reduction plans (including the 2022 Global Productivity Initiative), tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at www.colgatepalmolive.com.

Non-GAAP Financial Measures

The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:

• Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to an ERISA litigation matter, a foreign tax matter and the 2022 Global Productivity Initiative, product recall costs, goodwill and intangible assets impairment charges, a gain on the sale of land in Asia Pacific and acquisition-related costs.
• Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
• Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and twelve months ended December 31, 2023 versus 2022 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations” for the three and twelve months ended December 31, 2023 and 2022 included with this release for a reconciliation of these financial measures to the related GAAP measures.

The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the twelve months ended December 31, 2023 and 2022 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

(See attached tables for fourth quarter and full year results.)

						Table 1
Colgate-Palmolive Company
Condensed Consolidated Statements of Income
For the Three Months Ended December 31, 2023 and 2022
(Dollars in Millions Except Per Share Amounts) (Unaudited)
			2023				2022
Net sales		$	4,950			$	4,629
Cost of sales			2,000				2,055
Gross profit			2,950				2,574
Gross profit margin			59.6	%			55.6	%
Selling, general and administrative expenses			1,803				1,633
Other (income) expense, net			75				18
Goodwill and intangible assets impairment charges			—				721
Operating profit			1,072				202
Operating profit margin			21.7	%			4.4	%
Non-service related postretirement costs			22				15
Interest (income) expense, net			62				55
Income before income taxes			988				132
Provision for income taxes			228				89
Effective tax rate			23.1	%			67.4	%
Net income including noncontrolling interests			760				43
Less: Net income attributable to noncontrolling interests			42				38
Net income attributable to Colgate-Palmolive Company		$	718			$	5
Earnings per common share
Basic		$	0.87			$	0.01
Diluted		$	0.87			$	0.01
Supplemental Income Statement Information
Average common shares outstanding
Basic			823.4				832.6
Diluted			825.1				834.4
Advertising		$	593			$	504

						Table 2
Colgate-Palmolive Company
Condensed Consolidated Statements of Income
For the Twelve Months Ended December 31, 2023 and 2022
(Dollars in Millions Except Per Share Amounts) (Unaudited)
			2023				2022
Net sales		$	19,457			$	17,967
Cost of sales			8,131				7,719
Gross profit			11,326				10,248
Gross profit margin			58.2	%			57.0	%
Selling, general and administrative expenses			7,151				6,565
Other (income) expense, net			191				69
Goodwill and intangible assets impairment charges			—				721
Operating profit			3,984				2,893
Operating profit margin			20.5	%			16.1	%
Non-service related postretirement costs			360				80
Interest (income) expense, net			232				153
Income before income taxes			3,392				2,660
Provision for income taxes			937				693
Effective tax rate			27.6	%			26.1	%
Net income including noncontrolling interests			2,455				1,967
Less: Net income attributable to noncontrolling interests			155				182
Net income attributable to Colgate-Palmolive Company		$	2,300			$	1,785
Earnings per common share
Basic(1)		$	2.78			$	2.13
Diluted(1)		$	2.77			$	2.13
Supplemental Income Statement Information
Average common shares outstanding
Basic			827.4				836.4
Diluted			829.2				838.8
Advertising		$	2,371			$	1,997

Note:

(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period.

						Table 3
Colgate-Palmolive Company
Condensed Consolidated Balance Sheets
As of December 31, 2023 and December 31, 2022
(Dollars in Millions) (Unaudited)
			2023				2022
Cash and cash equivalents		$	966			$	775
Receivables, net			1,586				1,504
Inventories			1,934				2,074
Other current assets			793				760
Property, plant and equipment, net			4,582				4,307
Goodwill			3,410				3,352
Other intangible assets, net			1,887				1,920
Other assets			1,235				1,039
Total assets		$	16,393			$	15,731
Total debt			8,549				8,766
Other current liabilities			4,411				3,979
Other non-current liabilities			2,476				2,180
Total liabilities			15,436				14,925
Total Colgate-Palmolive Company shareholders’ equity			609				401
Noncontrolling interests			348				405
Total liabilities and equity		$	16,393			$	15,731
Supplemental Balance Sheet Information
Debt less cash, cash equivalents and marketable securities(1)		$	7,404			$	7,816
Working capital % of sales			(1.4	)%			1.0	%

Note:

(1) Marketable securities of $179 and $175 as of December 31, 2023 and 2022, respectively, are included in Other current assets.

						Table 4
Colgate-Palmolive Company
Condensed Consolidated Statements of Cash Flows
For the Twelve Months Ended December 31, 2023 and 2022
(Dollars in Millions) (Unaudited)
			2023				2022
Operating Activities
Net income including noncontrolling interests		$	2,455			$	1,967
Adjustments to reconcile Net income including noncontrolling interests to Net cash provided by operations:
Depreciation and amortization			567				545
ERISA litigation matter			267				—
Restructuring and termination benefits, net of cash			(23	)			49
Stock-based compensation expense			122				125
Gain on the sale of land			—				(47	)
Goodwill and intangible assets impairment charges			—				721
Deferred income taxes			(98	)			(78	)
Cash effects of changes in:
Receivables			(37	)			(227	)
Inventories			194				(333	)
Accounts payable and other accruals			309				(115	)
Other non-current assets and liabilities			(11	)			(51	)
Net cash provided by operations			3,745				2,556
Investing Activities
Capital expenditures			(705	)			(696	)
Purchases of marketable securities and investments			(506	)			(470	)
Proceeds from sale of marketable securities and investments			502				322
Payment for acquisitions, net of cash acquired			—				(809	)
Proceeds from the sale of land			—				47
Other investing activities			(33	)			5
Net cash used in investing activities			(742	)			(1,601	)
Financing Activities
Short-term borrowing (repayment) less than 90 days, net			(906	)			540
Principal payments on debt			(903	)			(406	)
Proceeds from issuance of debt			1,495				1,513
Dividends paid			(1,749	)			(1,691	)
Purchases of treasury shares			(1,128	)			(1,308	)
Proceeds from exercise of stock options			380				418
Other financing activities			18				(18	)
Net cash used in financing activities			(2,793	)			(952	)
Effect of exchange rate changes on Cash and cash equivalents			(19	)			(60	)
Net increase (decrease) in Cash and cash equivalents			191				(57	)
Cash and cash equivalents at beginning of the period			775				832
Cash and cash equivalents at end of the period		$	966			$	775
Supplemental Cash Flow Information
Free cash flow before dividends (Net cash provided by operations less Capital expenditures)
Net cash provided by operations			3,745				2,556
Less: Capital expenditures			(705	)			(696	)
Free cash flow before dividends		$	3,040			$	1,860
Income taxes paid		$	937			$	945
Interest paid		$	280			$	151

														Table 5
Colgate-Palmolive Company
Segment Information
For the Three and Twelve Months Ended December 31, 2023 and 2022
(Dollars in Millions) (Unaudited)
		Three Months Ended December 31,								Twelve Months Ended December 31,
			2023				2022				2023				2022
Net Sales
Oral, Personal and Home Care
North America		$	999			$	966			$	3,925			$	3,816
Latin America			1,192				1,011				4,640				3,982
Europe			685				623				2,737				2,548
Asia Pacific			698				696				2,782				2,826
Africa/Eurasia			262				273				1,083				1,082
Total Oral, Personal and Home Care			3,836				3,569				15,167				14,254
Pet Nutrition			1,114				1,060				4,290				3,713
Total Net Sales		$	4,950			$	4,629			$	19,457			$	17,967
		Three Months Ended December 31,								Twelve Months Ended December 31,
			2023				2022				2023				2022
Operating Profit
Oral, Personal and Home Care
North America		$	242			$	204			$	892			$	761
Latin America			366				290				1,417				1,108
Europe			140				104				552				514
Asia Pacific			203				181				767				737
Africa/Eurasia			59				69				254				228
Total Oral, Personal and Home Care			1,010				848				3,882				3,348
Pet Nutrition			231				233				806				850
Corporate(1)			(169	)			(879	)			(704	)			(1,305	)
Total Operating Profit		$	1,072			$	202			$	3,984			$	2,893

Note:

(1) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.

Corporate Operating profit (loss) for the three months ended December 31, 2023 included charges resulting from the 2022 Global Productivity Initiative of $2.

Corporate Operating profit (loss) for the twelve months ended December 31, 2023 included charges resulting from the 2022 Global Productivity Initiative of $27 and product recall costs of $25.

Corporate Operating profit (loss) for the three months ended December 31, 2022 included goodwill and intangible assets impairment charges of $721, charges resulting from the 2022 Global Productivity Initiative of $15 and acquisition-related costs of $3.

Corporate Operating profit (loss) for the twelve months ended December 31, 2022 included goodwill and intangible assets impairment charges of $721, charges resulting from the 2022 Global Productivity Initiative of $95, a gain on the sale of land in Asia Pacific of $47 and acquisition-related costs of $19.

Table 6
Colgate-Palmolive Company
Geographic Sales Analysis Percentage Changes
For the Three Months Ended December 31, 2023 vs. 2022
(Unaudited)
								COMPONENTS OF SALES CHANGE
														Pricing
														Coupons
		Sales												Consumer &
		Change			Organic			As Reported			Organic			Trade			Foreign
Region		As Reported			Sales Change			Volume			Volume			Incentives			Exchange
Total Company		7.0	%		7.0	%		—	%		—	%		7.0	%		—	%
North America		3.5	%		3.5	%		0.5	%		0.5	%		3.0	%		—	%
Latin America		18.0	%		16.5	%		8.0	%		8.0	%		8.5	%		1.5	%
Europe		10.0	%		3.5	%		(4.0	)%		(4.0	)%		7.5	%		6.5	%
Asia Pacific		0.5	%		1.0	%		(4.5	)%		(4.5	)%		5.5	%		(0.5	)%
Africa/Eurasia		(4.0	)%		17.0	%		7.5	%		7.5	%		9.5	%		(21.0	)%
Total CP Products		7.5	%		7.5	%		1.0	%		1.0	%		6.5	%		—	%
Hill’s		5.0	%		4.5	%		(4.0	)%		(4.0	)%		8.5	%		0.5	%
Emerging Markets(1)		9.0	%		10.5	%		2.5	%		2.5	%		8.0	%		(1.5	)%
Developed Markets		5.5	%		4.0	%		(2.0	)%		(2.0	)%		6.0	%		1.5	%

Note:

(1) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

Table 7
Colgate-Palmolive Company
Geographic Sales Analysis Percentage Changes
For the Twelve Months Ended December 31, 2023 vs. 2022
(Unaudited)
								COMPONENTS OF SALES CHANGE
														Pricing
														Coupons
		Sales												Consumer &
		Change			Organic			As Reported			Organic			Trade			Foreign
Region		As Reported			Sales Change			Volume(1)			Volume			Incentives			Exchange
Total Company		8.5	%		8.5	%		(0.5	)%		(1.5	)%		10.0	%		(1.0	)%
North America		3.0	%		3.0	%		(4.5	)%		(4.5	)%		7.5	%		—	%
Latin America		16.5	%		15.5	%		2.5	%		2.5	%		13.0	%		1.0	%
Europe		7.5	%		5.0	%		(4.5	)%		(4.5	)%		9.5	%		2.5	%
Asia Pacific		(1.5	)%		2.5	%		(3.5	)%		(3.5	)%		6.0	%		(4.0	)%
Africa/Eurasia		—	%		17.5	%		4.5	%		4.5	%		13.0	%		(17.5	)%
Total CP Products		6.5	%		8.0	%		(1.5	)%		(1.5	)%		9.5	%		(1.5	)%
Hill’s		15.5	%		10.5	%		5.0	%		(0.5	)%		11.0	%		(0.5	)%
Emerging Markets(2)		8.0	%		11.0	%		—	%		—	%		11.0	%		(3.0	)%
Developed Markets		8.5	%		6.5	%		(0.5	)%		(2.5	)%		9.0	%		—	%

Notes:

(1) The impact of the previously disclosed acquisitions of pet food businesses on as reported volume was 1.0%, 5.5% and 2.0% for Total Company, Hill's and Developed Markets, respectively.

(2) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

Table 8
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Three Months Ended December 31, 2023 and 2022
(Dollars in Millions Except Per Share Amounts) (Unaudited)
Selling, General and Administrative Expenses			2023				2022
Selling, general and administrative expenses, GAAP		$	1,803			$	1,633
2022 Global Productivity Initiative			—				(1	)
Selling, general and administrative expenses, non-GAAP		$	1,803			$	1,632
Other (Income) Expense, Net			2023				2022
Other (income) expense, net, GAAP		$	75			$	18
2022 Global Productivity Initiative			(2	)			(14	)
Acquisition-related costs			—				(3	)
Other (income) expense, net, non-GAAP		$	73			$	1
Operating Profit			2023				2022			% Change
Operating profit, GAAP		$	1,072			$	202			431	%
2022 Global Productivity Initiative			2				15
Goodwill and intangible assets impairment charges			—				721
Acquisition-related costs			—				3
Operating profit, non-GAAP		$	1,074			$	941			14	%
										Basis Point
Operating Profit Margin			2023				2022			Change
Operating profit margin, GAAP			21.7	%			4.4	%		1,730
2022 Global Productivity Initiative			—	%			0.3	%
Goodwill and intangible assets impairment charges			—	%			15.5	%
Acquisition-related costs			—	%			0.1	%
Operating profit margin, non-GAAP			21.7	%			20.3	%		140
Non-service related post retirement cost			2023				2022
Non-service related post retirement cost, GAAP		$	22			$	15
2022 Global Productivity Initiative			(1	)			(2	)
Non-service post retirement cost, non-GAAP		$	21			$	13

Table 8
Continued
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Three Months Ended December 31, 2023 vs. 2022
(Dollars in Millions Except Per Share Amounts) (Unaudited)
		2023
		Income Before Income Taxes			Provision For Income Taxes(1)			Net Income Including Noncontrolling Interests			Net Income Attributable To Colgate- Palmolive Company			Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP		$	988		$	228		$	760		$	718		23.1	%		$	0.87
2022 Global Productivity Initiative			3			1			2			2		—	%			—
Non-GAAP		$	991		$	229		$	762		$	720		23.1	%		$	0.87
		2022
		Income Before Income Taxes			Provision For Income Taxes(1)			Net Income Including Noncontrolling Interests			Net Income Attributable To Colgate- Palmolive Company			Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP		$	132		$	89		$	43		$	5		67.4	%		$	0.01
Goodwill and intangible assets impairment charges			721			101			620			620		(45.1	)%			0.74
2022 Global Productivity Initiative			17			3			14			14		(0.1	)%			0.02
Acquisition-related costs			3			1			2			2		—	%			—
Non-GAAP		$	873		$	194		$	679		$	641		22.2	%		$	0.77

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Notes:

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

Table 9
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Twelve Months Ended December 31, 2023 vs. 2022
(Dollars in Millions Except Per Share Amounts) (Unaudited)
Gross Profit			2023				2022
Gross profit, GAAP		$	11,326			$	10,248
2022 Global Productivity Initiative			1				—
Gross profit, non-GAAP		$	11,327			$	10,248
Selling, General and Administrative Expenses			2023				2022
Selling, general and administrative expenses, GAAP		$	7,151			$	6,565
2022 Global Productivity Initiative			(2	)			(5	)
Selling, general and administrative expenses, non-GAAP		$	7,149			$	6,560
										Basis Point
Selling, General and Administrative Expenses as a Percentage of Net Sales			2023				2022			Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP			36.8	%			36.5	%		30
2022 Global Productive Initiative			(0.1	)%			—	%
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP			36.7	%			36.5	%		20
Other (Income) Expense, Net			2023				2022
Other (income) expense, net, GAAP		$	191			$	69
Product recall costs			(25	)			—
2022 Global Productivity Initiative			(24	)			(90	)
Gain on the sale of land in Asia Pacific			—				47
Acquisition-related costs			—				(19	)
Other (income) expense, net, non-GAAP		$	142			$	7
Operating Profit			2023				2022			% Change
Operating profit, GAAP		$	3,984			$	2,893			38	%
2022 Global Productivity Initiative			27				95
Product recall costs			25				—
Goodwill and intangible assets impairment charges			—				721
Gain on the sale of land in Asia Pacific			—				(47	)
Acquisition-related costs			—				19
Operating profit, non-GAAP		$	4,036			$	3,681			10	%
										Basis Point
Operating Profit Margin			2023				2022			Change
Operating profit margin, GAAP			20.5	%			16.1	%		440
2022 Global Productivity Initiative			0.1	%			0.5	%
Product recall costs			0.1	%			—	%
Goodwill and intangible assets impairment charges			—	%			4.0	%
Gain on the sale of land in Asia Pacific			—	%			(0.2	)%
Acquisition-related costs			—	%			0.1	%
Operating profit margin, non-GAAP			20.7	%			20.5	%		20
Non-service related post retirement cost			2023				2022
Non-service related post retirement cost, GAAP		$	360			$	80
ERISA litigation matter			(267	)			—
2022 Global Productivity Initiative			(5	)			(15	)
Non-service post retirement cost, non-GAAP		$	88			$	65

Table 9
Continued
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Twelve Months Ended December 31, 2023 vs. 2022
(Dollars in Millions Except Per Share Amounts) (Unaudited)
		2023
		Income Before Income Taxes					Provision For Income Taxes(1)				Net Income Including Noncontrolling Interests				Less: Income Attributable to Noncontrolling Interests				Net Income Attributable To Colgate- Palmolive Company				Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP		$		3,392			$	937			$	2,455			$	155			$	2,300			27.6	%		$	2.77
ERISA litigation matter				267				55				212				—				212			(0.5	)%			0.26
Foreign tax matter				—				(126	)			126				—				126			(3.4	)%			0.15
2022 Global Productivity Initiative				32				6				26				1				25			(0.1	)%			0.03
Product recall costs				25				6				19				—				19			—	%			0.02
Non-GAAP		$		3,716			$	878			$	2,838			$	156			$	2,682			23.6	%		$	3.23
		2022
		Income Before Income Taxes					Provision For Income Taxes(1)				Net Income Including Noncontrolling Interests				Less: Income Attributable to Noncontrolling Interests				Net Income Attributable To Colgate- Palmolive Company				Effective Income Tax Rate(2)			Diluted Earnings Per Share
As Reported GAAP		$		2,660			$	693			$	1,967			$	182			$	1,785			26.1	%		$	2.13
Goodwill and intangible assets impairment charges				721				101				620				—				620			(2.6	)%			0.74
2022 Global Productivity Initiative				110				22				88				1				87			(0.1	)%			0.10
Gain on the sale of land in Asia Pacific				(47	)			(11	)			(36	)			(21	)			(15	)		—	%			(0.02	)
Acquisition-related costs				19				3				16				—				16			(0.1	)%			0.02
Non-GAAP		$		3,463			$	808			$	2,655			$	162			$	2,493			23.3	%		$	2.97

The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

Notes:

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240126278873/en/

Investor Relations: investor_relations@colpal.com

Communications: colgate_palmolive_media_inquiry@colpal.com

Source: Colgate-Palmolive Company

FAQ

What were Colgate-Palmolive Company's (NYSE:CL) net sales and organic sales growth for the fourth quarter and full year 2023?

Colgate-Palmolive Company reported a 7.0% increase in net sales and organic sales for the fourth quarter and an 8.5% increase for the full year 2023.

What were the full-year total net sales and GAAP EPS for Colgate-Palmolive Company in 2023?

Full-year total net sales for Colgate-Palmolive Company were $19,457 million, with a 30% increase in GAAP EPS to $2.77.

What was the Base Business EPS for Colgate-Palmolive Company in 2023?

Base Business EPS for Colgate-Palmolive Company increased 9% to $3.23 in 2023.

What is Colgate-Palmolive Company's 2024 guidance for net sales and organic sales growth?

Colgate-Palmolive Company expects net sales growth to be 1% to 4% for 2024, including a low-single-digit negative impact from foreign exchange. The company also expects organic sales growth within the 3% to 5% targeted range.

What is Colgate-Palmolive Company's 2024 guidance for earnings-per-share growth on a GAAP basis?

On a GAAP basis, Colgate-Palmolive Company expects double-digit earnings-per-share growth for 2024.